Skip to content

Ambrisentan

Ambrisentan (Letairis) is an endothelin receptor antagonist listed for pulmonary arterial hypertension. This catalogue lists it in two products: Letairis on its own and Endobloc T Kit, which pairs it with tadalafil.

Endobloc T Kit

Pulmonary Arterial Hypertension

5mg + 20mg

Ambrisentan and tadalafil tablets for pulmonary arterial hypertension. The combination targets two different pathways to lower blood pressure in the lungs.

From$17.25/ tabletView

Letairis

Pulmonary Arterial Hypertension

5mg

Ambrisentan tablets for pulmonary arterial hypertension. It blocks a chemical that constricts lung arteries, easing strain on the heart.

From$14.65/ tabletView

Key points

  • Ambrisentan belongs to a class of medicines called endothelin receptor antagonists, which work by blocking a substance that narrows blood vessels in the lungs.
  • It carries a serious pregnancy warning because it can cause birth defects.
  • The two products differ in strength: Letairis is a standalone 5mg tablet, while Endobloc T Kit pairs 5mg ambrisentan with 20mg tadalafil in one tablet.

Brands and forms in this catalogue

Letairis is the originator ambrisentan brand, from Gilead Sciences. Endobloc T Kit is manufactured by Cipla. Both are listed for Pulmonary Arterial Hypertension and sit in the catalogue’s Heart & Blood Pressure category.

Further reading